Word

44

Status

Registered

Status Code

700

Status Date

Tuesday, May 21, 2024

Serial Number

97597522

Registration Number

7392925

Registration Date

Tuesday, May 21, 2024

Mark Type

3

Filing Date

Monday, September 19, 2022

Published for Opposition

Tuesday, August 22, 2023

Trademark Owner History

Avidity Biosciences, Inc. - Original Registrant

Classifications

5 Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

42 Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology

The mark consists of the 44 text inside of a partially full circle a top of a boat with 2 parallel wavy lines with one longer than the other at the bottom of the boat.
FORTY FOUR; FOUR FOUR
Color is not claimed as a feature of the mark.

Trademark Events

Jul 10, 2023

Non-Final Action Written

Sep 22, 2022

New Application Entered

Oct 5, 2022

New Application Office Supplied Data Entered

Oct 6, 2022

Notice Of Design Search Code E-Mailed

Jun 28, 2023

Assigned To Examiner

Jul 10, 2023

Non-Final Action E-Mailed

Jul 10, 2023

Notification Of Non-Final Action E-Mailed

Jul 13, 2023

Teas Response To Office Action Received

Jul 13, 2023

Correspondence Received In Law Office

Jul 14, 2023

Teas/Email Correspondence Entered

Jul 17, 2023

Approved For Pub - Principal Register

Aug 2, 2023

Notification Of Notice Of Publication E-Mailed

Aug 22, 2023

Published For Opposition

Oct 17, 2023

Noa E-Mailed - Sou Required From Applicant

Mar 19, 2024

Use Amendment Filed

Mar 19, 2024

Teas Statement Of Use Received

Apr 8, 2024

Case Assigned To Intent To Use Paralegal

Aug 22, 2023

Official Gazette Publication Confirmation E-Mailed

Apr 9, 2024

Statement Of Use Processing Complete

Apr 17, 2024

Allowed Principal Register - Sou Accepted

Apr 18, 2024

Notice Of Acceptance Of Statement Of Use E-Mailed

May 21, 2024

Registered-Principal Register

May 21, 2024

Notice Of Registration Confirmation Emailed